Failure to recover from acute, reversible effects of prior therapy regardless of interval since last treatment\r\n* EXCEPTION: Grade  peripheral (sensory) neuropathy that has been stable for at least  months since completion of prior treatment
Failed to recover from the reversible effects of prior anticancer therapies with the exception of alopecia and grade  neuropathy
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment.
Has failed to recover from the reversible effects of prior anticancer therapy
Failure to recover to =< grade  from acute, reversible effects of prior chemotherapy, excluding alopecia regardless of interval since last treatment; (NOTE: patients with residual peripheral neuropathy are allowed)
Failed to recover from the reversible effects of prior anticancer therapies with the exception of alopecia
Failure to recover from acute, reversible effects of prior therapy regardless of interval since last treatment\r\n* NOTE: Patients can have peripheral (sensory) neuropathy
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to fully recover (i.e. =< grade  adverse event [AE]) from the reversible effects of prior chemotherapy
Fully recovered from acute, reversible effects of prior therapy regardless of interval since last treatment;\r\n* EXCEPTION: neuropathies  if grade  neuropathies have been stable for at least  months since completion of prior treatment patient is eligible
Failed to recover to baseline or stable grade  from the reversible effects of prior anticancer therapies with the exception of alopecia
Failure to fully recover from acute, reversible effects defined as =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version (v.) . of prior chemotherapy regardless of interval since last treatment except alopecia and neuropathy
Patient must recover fully from hepatic resection
Failure to fully recover from acute, reversible effects defined as =< grade  Common Terminology Criteria for Adverse Events (CTCAE) version (v.) . of prior chemotherapy regardless of interval since last treatment
Failure to fully recover from acute, reversible effects of prior anti-cancer therapy regardless of interval since last treatment; NOTE: patients must have fully recovered from all acute, reversible toxicities (defined as Common Terminology Criteria for Adverse Events [CTCAE] . =< grade ) associated with previous treatment
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to fully recover from acute, reversible effects of prior chemotherapy (other anti-neoplastic therapy) and radiation therapy
Failure to recover fully (as judged by the investigator) from prior surgical procedures, or failure to recover from adverse events (grade =< ) due to agents administered more than  weeks earlier
Failure to fully recover from acute, reversible effects of prior chemotherapy (other anti-neoplastic therapy) and radiation therapy to adverse event severity of =< grade 
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to fully recover from side effects of prior therapy or surgery
Failure to recover to grade =<  from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failure to recover from the reversible effects of prior anticancer therapies with the exception of alopecia, and after-effects associated with prior tyrosine kinase inhibitor therapy such as hair depigmentation, hypothyroidism, and/or splinter hemorrhage.
Failure to fully recover from acute, reversible effects of prior chemotherapy regardless of interval since last treatment
Failed to recover from the reversible effects of prior anticancer therapies
Failure to fully recover from acute, reversible effects of prior surgery or chemotherapy regardless of interval since last treatment
Failed to recover from the reversible effects of prior anticancer therapies;